Before you sell to, join or invest in X1 Biotech Inc.
MentionFox check on X1 Biotech Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/x1-biotech-inc-form-d-25000001
Check X1 Biotech Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about X1 Biotech Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
X1 Biotech Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-05-21.
X1 Biotech Inc. filed an amended Form D notice of an exempt securities offering with the SEC on May 21, 2025. The filing reports $95K sold. Its industry group is Other Technology. It names Lawrence Kaufman (Executive Officer), Michael Aceti (Executive Officer), Leo Kim (Director) (SEC Form D/A, May 21, 2025).
Is this your company?
Sell to companies like X1 Biotech Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns X1 Biotech Inc.
Free to see. No signup.
More on the people and the money behind X1 Biotech Inc., from the filings we hold.
Other Technology raises by companies based in Massachusetts, filed in May 2025, largest first.
Get an email when X1 Biotech Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when X1 Biotech Inc. raises, hires or launches. No email unless you switch it on.
Watch X1 Biotech Inc. →Get the full cited report on X1 Biotech Inc.
What the filing shows about X1 Biotech Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on X1 Biotech Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives X1 Biotech Inc.'s address as 935 Great Plain Avenue, #140, Needham, MA 02492.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for X1 Biotech Inc. →
Amended on 2025-12-11: the offering size changed from $200,000 to $300,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
X1 Biotech Inc. is a registered filer with the SEC (CIK 2068848) and has filed since 2025-05-21. 4 filings are on record, the latest on 2026-06-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
X1 Biotech Inc.'s Form D of 2025-05-21 names Lawrence Kaufman, Michael Aceti, Leo Kim and 2 more as its officers, directors or promoters.
Its new offerings report $235K sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3839 filings in Other Technology, totalled by week.
Lawrence Kaufman is named as Executive Officer on the Form D that X1 Biotech Inc. filed with the SEC on 21 May 2025, one of 5 people that filing names.
Michael Aceti is named as Executive Officer on the Form D that X1 Biotech Inc. filed with the SEC on 21 May 2025, one of 5 people that filing names.
Leo Kim is named as Director on the Form D that X1 Biotech Inc. filed with the SEC on 21 May 2025, one of 5 people that filing names.
Joseph Arboleda-Valasquez is named as Director on the Form D that X1 Biotech Inc. filed with the SEC on 21 May 2025, one of 5 people that filing names.
Dean Eliott is named as Director on the Form D that X1 Biotech Inc. filed with the SEC on 21 May 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-05-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about X1 Biotech Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on X1 Biotech Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on X1 Biotech Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist X1 Biotech Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind X1 Biotech Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for X1 Biotech Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/x1-biotech-inc-form-d-25000001